Physician profile
Christopher D Cotton
NPI 1841271681
$1,163.77
in general payments reported to CMS, 2019-2025
10 companies · $29.03 in 2025
The $29.03 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.10 · 2021: $13.88 · 2022: $56.33 · 2023: $985 · 2024: $26.90 · 2025: $29.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $726 · Food and Beverage: $158 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $726.28 |
| Food and Beverage | $158.19 |
| Education | $155.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $726.28 | 2023 | Mako |
| Astellas Pharma US INC | $174.09 | 2023 | Veozah |
| Lilly USA, LLC | $57.09 | 2021-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $53.02 | 2022-2024 | |
| Pfizer INC. | $46.37 | 2022-2023 | |
| Novo Nordisk INC | $32.68 | 2019-2023 | Rybelsus, Ozempic |
| Sanofi Pasteur INC. | $24.56 | 2023 | |
| Mylan Specialty L.P. | $21.13 | 2019 | |
| Aytu Biopharma, INC. | $16.42 | 2019 | |
| Amgen INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.